50 / 88
50
Scientific Programme /
Wednesday, 21 June 2017
WFSBP 2017
WED
aa
Wednesday, 21 June 2017
T2: ANTIDEPRESSANTS: BASIC/ CLINICAL
S-43
SYMPOSIUM
08:30–10:00
Auditorium 15
Novel approaches in mechanisms of action of
antidepressant treatment
Chair:
Rainer Rupprecht, Germany
Co-Chair: Mark Rasenick, USA
001
Signal transduction in membranes as mechanism
of action of antidepressants
Mark Rasenick, USA
002
Cytoskeleton as target for antidepressants
Massimiliano Bianchi, Ireland
003
Biomarkers during antidepressant treatment
Thomas Baghai, Germany
004
Antidepressants may affect signaling independent-
ly from monoamine reuptake
Rainer Rupprecht, Germany
T17: GENETICS
S-44
SYMPOSIUM
08:30–10:00
Congress Hall A 3
Cannabinoid Receptor (CBR) gene variations in
neuropsychiatric disorders
Chair:
Hiroki Ishiguro, Japan
Co-Chair: Emmanuel Onaivi, USA
001
Environmental stressors induce psychosis based on
genetic variation of CB2Rs
Hiroki Ishiguro, Japan
002
ECB system alteration in an animal model of
autism spectrum disorders
Eugene Dennis, USA
004
CBR genetics: From mice to human subjects
Emmanuel Onaivi, USA
003
Species differences in CBR genes
Emmanuel Onaivi, USA
T1: ADDICTIVE DISORDERS
S-45
SYMPOSIUM
08:30–10:00
Auditorium 10
Behavioral addictions: Diagnosis, co-morbidity and
neurobiology
Chair:
Michel Lejoyeux, France
Co-Chair: Aviv Weinstein, Israel
001
Internet gaming disorder- addiction, co-morbidity
and the brain
Aviv Weinstein, Israel
002
Neuroimaging evidence for considering hyper-
sexuality as an addiction
Florence Thibaut, France
003
New data on phenomenology and psychiatric
comorbidity of compulsive buying
Michel Lejoyeux, France
004
The genetic background of gambling behavior
Csaba Barta, Hungary
Z. Demetrovics, E. Kótyuk, A. Vereczkei, R. Urbán,
A. Eisinger, A. Magi, G. Kökönyei, A. Veres-Székely,
Á. Gyollai, K. Blum, M. Sasvári-Székely
T50: VIOLENCE: BASIC/ CLINICAL
S-46
SYMPOSIUM
08:30–10:00
Auditorium 11
Neurobiology and psychopharmacology of aggressive
behaviour: Where are we?
Chair:
Stefano Comai, Italy
Co-Chair: Gabriella Gobbi, Canada
001
Neurobiology and biomarkers of aggression
Stefano Comai, Italy
002
Clinical management of aggression in childhood
and adolescence
Pradeep Rao, Australia
003
Substance use disorders and aggressive behaviour
Gabriella Gobbi, Canada
004
Epilepsy, antiepileptic drugs and aggression
Martin J. Brodie, United Kingdom